Moderna logo

Co-Op, Clinical Biomarker Biostatistics

Moderna

Cambridge, MAHybridPosted 24 days ago$20.00 - $60.00/hour
InternshipInternBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

This is a full-time Co-op position based in Cambridge, MA from January 18th - June 25th, 2027. Candidates must be available for the entire duration of the program. Moderna's Biometrics organization is seeking a highly-motivated Biostatistics internship to help address complex quantitative challenges and generate high-impact evidence that informs the development of mRNA vaccines and therapeutics.

Job description

As a Biostatistics internship, you will work alongside experienced statisticians and cross-functional scientists as an integral member of high-performing project teams. You will have the opportunity to develop, evaluate, and apply fit-for-purpose statistical methodologies to real-world clinical development questions, with a particular focus on biomarkers, causal inference, correlates of protection (CoP), and surrogate endpoints.

Here's What You'll Do

  • Develop and apply fit-for-purpose statistical and causal inference approaches to evaluate biomarkers as potential CoP and surrogate endpoints for clinical benefit.
  • Explore causal frameworks for surrogate endpoint evaluation, including mediation analysis, controlled efficacy, principal stratification, and other emerging methodologies, as appropriate to the scientific question.
  • Design and conduct simulation studies to evaluate statistical properties, operating characteristics, and robustness of proposed methods under clinically relevant scenarios.
  • Apply statistical methods to clinical trial and biomarker data to characterize relationships among treatment, immune or biological responses, and clinical outcomes.

Here's What You'll Need (Minimum Qualifications)

  • Currently enrolled in a PhD program in Biostatistics, Statistics, Applied Mathematics, Data Science, or a related quantitative field.
  • Graduate-level training or research experience in statistical methodology, including regression, survival analysis, and causal inference.
  • Academic or research experience with causal inference and machine learning/or deep learning methodologies.
  • Proficiency in R (or SAS, Python) for statistical analyses, methodology research, and simulation studies.

Here's What You'll Bring to the Table (Preferred Qualifications)

  • GPA of 3.5 or higher on a 4.0 scale, or equivalent academic achievement.
  • Research experience in causal inference, biomarkers, correlates of protection (CoP), surrogate endpoints, clinical trials, or related biomedical applications.
  • Strong interest in developing and applying innovative statistical methodologies to accelerate the development of mRNA vaccines and therapeutics.
  • Experience with simulation studies, machine learning/deep learning, or advanced statistical modeling.
  • Peer-reviewed publications, conference presentations, manuscripts, or other demonstrated experience in academic research and scientific communication.
  • Ability to work independently while collaborating effectively within multidisciplinary teams.
  • Strong written and verbal scientific communication skills.

Requirements

  • Currently enrolled in a PhD program in Biostatistics, Statistics, Applied Mathematics, Data Science, or a related quantitative field.
  • Graduate-level training or research experience in statistical methodology, including regression, survival analysis, and causal inference.
  • Academic or research experience with causal inference and machine learning/or deep learning methodologies.
  • Proficiency in R (or SAS, Python) for statistical analyses, methodology research, and simulation studies.

Benefits

  • Meditation and mindfulness classes
  • Subsidized commuter benefits
  • Paid time off
  • Vacation
  • Sick time
  • Holidays
  • Volunteer days
  • Discretionary year-end shutdown

Company overview

Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.